| Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease. | |
| | |
MedLine Citation:
|
PMID: 20504221 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Death certificates are used to classify cause of death for studies of cancer survival and mortality. Using data from the National Cancer Institute's Surveillance, Epidemiology, and End Results program, we evaluated cause of death (site-specific, cancer cause-specific, or other cause of death) for 229,181 patients with distant stage disease during 1994-2003 who died by 2005. Agreement between coded cause of death and initial diagnosis was 85% in patients with only one primary and 64% in patients with more than one primary. Our findings support the usefulness of site and cancer cause-specific causes of death reported on the death certificate for distant stage patients with a single cancer. |
| | |
Authors:
|
Jennifer L Lund; Linda C Harlan; K Robin Yabroff; Joan L Warren |
Publication Detail:
|
Type: Evaluation Studies; Journal Article |
Journal Detail:
|
Title: Cancer investigation Volume: 28 ISSN: 1532-4192 ISO Abbreviation: Cancer Invest. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-19 Completed Date: 2010-07-27 Revised Date: 2011-09-20 |
Medline Journal Info:
|
Nlm Unique ID: 8307154 Medline TA: Cancer Invest Country: England |
Other Details:
|
Languages: eng Pagination: 758-64 Citation Subset: IM |
Affiliation:
|
Department of Epidemiology, University of North Carolina, Chapel Hill, 27599-7435, USA. jlund@email.unc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Cause of Death* Data Collection* Death Certificates* Female Humans Male Middle Aged Neoplasms / mortality* Neoplasms, Multiple Primary / mortality SEER Program |
| Grant Support | |
ID/Acronym/Agency:
|
T32 DK007634-09/DK/NIDDK NIH HHS |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: In vivo and In Vitro Antitumor Effects of a Staphylococcal Enterotoxin A Mutant (SEA-H61D).
Next Document: Optimizing the Use of Sunitinib in Metastatic Renal Cell Carcinoma: An Update From Clinical Practice...